Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cimetropium
2. Da 3177
3. Da-3177
4. Scopolamine N-(cyclopropylmethyl)bromide
1. Alginor
2. 51598-60-8
3. Cimetropium Bromide [inn]
4. 0c7m5we60q
5. Da-3177
6. [(1s,2s,4r,5r)-9-(cyclopropylmethyl)-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2s)-3-hydroxy-2-phenylpropanoate;bromide
7. Cimetropii Bromidum
8. Bromuro De Cimetropio
9. Bromure De Cimetropium
10. Cimetropii Bromidum [latin]
11. Unii-0c7m5we60q
12. Bromure De Cimetropium [french]
13. Bromuro De Cimetropio [spanish]
14. Schembl26842
15. Chembl2105977
16. Cimetropium Bromide [mi]
17. Cimetropium Bromide [jan]
18. Cimetropium Bromide [mart.]
19. Cimetropium Bromide [who-dd]
20. Hy-u00106
21. Cs-7142
22. Da 3177
23. 8-(cyclopropylmethyl)-6beta,7beta-epoxy-3alpha-((s)-tropoyl)-1alphah,5alphah-tropanium Bromid
24. 8-(cyclopropylmethyl)-6beta,7beta-epoxy-3alpha-hydroxy-1alphah,5alphah-tropanium Bromide, (-)-(s)-tropate
25. N-cyclopropylmethylscopolamine Bromide
26. (7(s)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.))-9-(cyclopropylmethyl)-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane Bromide
27. (7(s)-(1alpha,2beta,4beta,5alpha,7beta))-9-(cyclopropylmethyl)-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-3-oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane Bromide
28. 3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane, 9-(cyclopropylmethyl)-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, Bromide, (7(s)-(1alpha,2beta,4beta,5alpha,7beta))-
29. 3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 9-(cyclopropylmethyl)-7-((2s)-3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, Bromide (1:1), (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-
Molecular Weight | 438.4 g/mol |
---|---|
Molecular Formula | C21H28BrNO4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 437.12017 g/mol |
Monoisotopic Mass | 437.12017 g/mol |
Topological Polar Surface Area | 59.1 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 538 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03B - Belladonna and derivatives, plain
A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
A03BB05 - Cimetropium bromide
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?